These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 8743897)
1. Regulatory mutations in human lipoprotein disorders and atherosclerosis. Kontula K; Ehnholm C Curr Opin Lipidol; 1996 Apr; 7(2):64-8. PubMed ID: 8743897 [TBL] [Abstract][Full Text] [Related]
2. Small genetic effects in complex diseases: a review of regulatory sequence variants in dyslipoproteinemia and atherosclerosis. Hegele RA Clin Biochem; 1997 Apr; 30(3):183-8. PubMed ID: 9167893 [TBL] [Abstract][Full Text] [Related]
3. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses. Peacock RE; Hamsten A; Johansson J; Nilsson-Ehle P; Humphries SE Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891 [TBL] [Abstract][Full Text] [Related]
4. Interaction of the common apolipoprotein C-III (APOC3 -482C > T) and hepatic lipase (LIPC -514C > T) promoter variants affects glucose tolerance in young adults. European Atherosclerosis Research Study II (EARS-II). Jansen H; Waterworth DM; Nicaud V; Ehnholm C; Talmud PJ; Ann Hum Genet; 2001 May; 65(Pt 3):237-43. PubMed ID: 11427182 [TBL] [Abstract][Full Text] [Related]
5. Distal apolipoprotein C-III regulatory elements F to J act as a general modular enhancer for proximal promoters that contain hormone response elements. Synergism between hepatic nuclear factor-4 molecules bound to the proximal promoter and distal enhancer sites. Kardassis D; Tzameli I; Hadzopoulou-Cladaras M; Talianidis I; Zannis V Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):222-32. PubMed ID: 9012660 [TBL] [Abstract][Full Text] [Related]
6. Effect of genetic variation on the postprandial response. Results from the European Atherosclerosis Research Study II. Talmud PJ; Waterworth DM; Humphries SE; World Rev Nutr Diet; 2001; 89():53-60. PubMed ID: 11530737 [No Abstract] [Full Text] [Related]
7. [Polymorphisms in genes for cholesterol ester transfer protein, apolipoprotein C-III and lipoprotein lipase in children with high and low cholesterol levels] ]. Hubácek JA; Pistulková H; Skodová Z; Lánská V; Poledne R Cas Lek Cesk; 2001 Feb; 140(3):79-81. PubMed ID: 11284423 [TBL] [Abstract][Full Text] [Related]
8. Genetic determinants of atherosclerosis-related dyslipidemias and their clinical implications. Galton DJ Clin Chim Acta; 1997 Jan; 257(2):181-97. PubMed ID: 9118562 [TBL] [Abstract][Full Text] [Related]
11. Transgenic mouse models of lipoprotein metabolism and atherosclerosis. Breslow JL Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8314-8. PubMed ID: 8378301 [TBL] [Abstract][Full Text] [Related]
12. Lipoprotein mutations in pigs are associated with elevated plasma cholesterol and atherosclerosis. Rapacz J; Hasler-Rapacz J; Taylor KM; Checovich WJ; Attie AD Science; 1986 Dec; 234(4783):1573-7. PubMed ID: 3787263 [TBL] [Abstract][Full Text] [Related]
13. Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: interaction between genotype, gender, and smoking status. Peacock RE; Temple A; Gudnason V; Rosseneu M; Humphries SE Genet Epidemiol; 1997; 14(3):265-82. PubMed ID: 9181356 [TBL] [Abstract][Full Text] [Related]
14. A DNA insertion in the apolipoprotein A-I gene of patients with premature atherosclerosis. Karathanasis SK; Zannis VI; Breslow JL Nature; 1983 Oct 27-Nov 2; 305(5937):823-5. PubMed ID: 6314145 [TBL] [Abstract][Full Text] [Related]
15. Influence of apolipoproteins on the anatomical distribution of arterial disease. Wiseman SA; Powell JT; Barber N; Humphries SE; Greenhalgh RM Atherosclerosis; 1991 Aug; 89(2-3):231-7. PubMed ID: 1686549 [TBL] [Abstract][Full Text] [Related]
16. Lipoprotein concentrations in newborns are associated with allelic variations in their mothers. Descamps OS; Bruniaux M; Guilmot PF; Tonglet R; Heller FR Atherosclerosis; 2004 Feb; 172(2):287-98. PubMed ID: 15019539 [TBL] [Abstract][Full Text] [Related]
17. Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice. Jong MC; Havekes LM Int J Tissue React; 2000; 22(2-3):59-66. PubMed ID: 10937355 [TBL] [Abstract][Full Text] [Related]
18. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis. Vergnes L; Baroukh N; Ostos MA; Castro G; Duverger N; Nanjee MN; Najib J; Fruchart JC; Miller NE; Zakin MM; Ochoa A Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2267-74. PubMed ID: 11031214 [TBL] [Abstract][Full Text] [Related]
19. Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins. Hegele RA; Connelly PW; Hanley AJ; Sun F; Harris SB; Zinman B Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2753-8. PubMed ID: 9409252 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo. Zannis VI; Kan HY; Kritis A; Zanni EE; Kardassis D Curr Opin Lipidol; 2001 Apr; 12(2):181-207. PubMed ID: 11264990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]